CA125 as a serum marker for poor prognosis in ovarian malignancies
Authors:
- Ronald D. AlvarezRARonald D. Alvarez
- Alexander ToATAlexander To
- Larry R. BootsLBLarry R. Boots
- Hugh M. ShingletonHSHugh M. Shingleton
- Kenneth D. HatchKHKenneth D. Hatch
- Judy HubbardJHJudy Hubbard
- Seng Jaw SoongSSSeng Jaw Soong
- Mark E. PotterMPMark E. Potter
- 1 March 1987
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 26 (3) , 284-289
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- CA 125 Serum Levels Correlated With Second-Look Operations Among Ovarian Cancer PatientsObstetrics & Gynecology, 1986
- ROLE OF CA-125 AS TUMOR-MARKER IN OVARIAN-CARCINOMA1986
- Predictive value of CA 125 antigen levels in second-look procedures for ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1985
- Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour markerBritish Journal of Cancer, 1984
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983